Accounting reportsPreviously
|
Name | IMPLANTA, ZAO |
|---|
INN | 7718134300 |
|---|
KPP | 770401001 |
|---|
OGRN | 1027739433281 |
|---|
OKPO | 18681816 |
|---|
FFSM | 13152-H |
|---|
Address | 119002, G.moskva, per. Karmanitskiy, d. D.9 |
|---|
Phone | 234-91-19 Contact details |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 46.46 | Core activity | Wholesale of pharmaceutical goods | | 21.20.2 | Additional activity | Production of materials used in medical applications | | 26.60 | Additional activity | Manufacture of irradiation and electrotherapeutic equipment used for medical purposes | | All types of activities | | 32.50 | Additional activity | Dental Laboratories | | 33.13 | Additional activity | Repair of electronic and optical equipment | | 46.18.12 | Additional activity | Agents specialized in the wholesale products used for medical purposes | | 46.18.3 | Additional activity | Agents specialized in the wholesale trade of machinery, equipment and tools used for medical purposes | | 46.46.2 | Additional activity | Wholesale of medical and orthopedic goods, dental and laboratory supplies | | 46.69.8 | Additional activity | Wholesale trade machinery, equipment and tools used for medical purposes | | 47.74 | Additional activity | Retailing products used for medical purposes, orthopedic goods in specialized stores | | 77.39.26 | Additional activity | Rental and leasing of equipment, vehicles and other equipment used for medical purposes | | 77.40 | Additional activity | Rental of intellectual property and similar products, except copyright |
Registration date | 22.10.2002 |
|---|
Registering department | Gosudarstvennoe uchrezhdenie Moskovskaya registratsionnaya palata |
|---|
|
IMPLANTA, ZAO (Moscow; INN 7718134300) was registered on 22 Oct 2002. The company's authorized capital as of July 1, 2012 was 10000 rub. Type of ownership of IMPLANTA, ZAO - Closed joint-stock companies. Form of ownership of IMPLANTA, ZAO - Property of foreign legal entities. Principal activities of IMPLANTA, ZAO: wholesale of pharmaceutical goods (46.46), production of materials used in medical applications (21.20.2), manufacture of irradiation and electrotherapeutic equipment used for medical purposes (26.60). |
Economic indicators2023
Net loss (RA) of IMPLANTA, ZAO made up 74.30 million RUB over 2023 compared to net profit of 78.86 million RUB over 2022, the company informed. Revenue increased in the accounting period by 8.81% to 773.10 million RUB from 710.48 million RUB over 2022; cost of goods sold grew by 14.69% to 557.96 million RUB from 486.50 million RUB; sales profit fell by 41.60% to 25.86 million RUB from 44.27 million RUB. 2022
Net profit (RAS) of IMPLANTA, ZAO grew over 2022 2.31 times to 78.86 million RUB from 34.16 million RUB over 2021, the company informed. Revenue decreased in the accounting period by 36.37% to 710.48 million RUB from 1.12 billion RUB in 2021; cost of goods sold decreased by 42.78% to 486.50 million RUB from 850.26 million RUB; sales profit fell by 41.44% to 44.27 million RUB from 75.60 million RUB. 2021
Net profit (RAS) of IMPLANTA, ZAO made up 34.16 million RUB over 2021 compared to net loss of 35.30 million RUB over 2020, the company informed. Revenue decreased in the accounting period by 19.31% to 1.12 billion RUB from 1.38 billion RUB in 2020; cost of goods sold decreased by 18.54% to 850.26 million RUB from 1.04 billion RUB; sales profit fell by 44.63% to 75.60 million RUB from 136.54 million RUB. 2020
Net loss (RA) of IMPLANTA, ZAO made up 35.30 million RUB over 2020 compared to net profit of 22.45 million RUB over 2019, the company informed. Revenue increased in the accounting period by 19.17% to 1.38 billion RUB from 1.16 billion RUB over 2019; cost of goods sold grew by 7.48% to 1.04 billion RUB from 971.14 million RUB; sales profit made up 136.54 million RUB compared to sales loss of 26.08 million RUB. 2018
Net loss (RA) of IMPLANTA, ZAO made up 200.49 million RUB over 2018 compared to net profit of 27.00 million RUB over 2017, the company informed. Revenue decreased in the accounting period by 15.03% to 1.18 billion RUB from 1.38 billion RUB in 2017; cost of goods sold decreased by 12.41% to 1.01 billion RUB from 1.16 billion RUB; sales loss made up 42.55 million RUB compared to sales profit of 30.94 million RUB. 2017
Net profit (RAS) of IMPLANTA, ZAO made up 27.00 million RUB over 2017 compared to net loss of 85.58 million RUB over 2016, the company informed. Revenue decreased in the accounting period by 9.92% to 1.38 billion RUB from 1.54 billion RUB in 2016; cost of goods sold decreased by 15.99% to 1.16 billion RUB from 1.38 billion RUB; sales profit made up 30.94 million RUB compared to sales loss of 22.79 million RUB. 2016
Net loss (RAS) of IMPLANTA, ZAO dropped over 2016 by 6.97% to 85.58 million RUB from 91.99 million RUB KAgent.Entities.Balance, the company informed. Revenue increased in the accounting period by 18.01% to 1.54 billion RUB from 1.30 billion RUB over 2015; cost of goods sold grew by 21.11% to 1.38 billion RUB from 1.14 billion RUB; sales loss decreased by 32.74% to 22.79 million RUB from 33.88 million RUB. 2014
Net loss (RA) of IMPLANTA, ZAO made up 248.19 million RUB over 2014 compared to net profit of 15.69 million RUB over 2013, the company informed. Revenue increased in the accounting period by 17.03% to 1.83 billion RUB from 1.56 billion RUB over 2013; cost of goods sold grew by 24.05% to 1.61 billion RUB from 1.30 billion RUB; sales profit fell by 45.51% to 46.87 million RUB from 86.02 million RUB. 2013
Net profit (RAS) of IMPLANTA, ZAO dropped in 2013 by 5.64% to 15.69 million RUB from 16.62 million RUB over the same period in 2012, the company informed. Revenue increased in the accounting period by 33.42% to 1.56 billion RUB from 1.17 billion RUB over 2012; cost of goods sold grew by 31.86% to 1.30 billion RUB from 982.45 million RUB; sales profit went up 2.56 times to 86.02 million RUB from 33.56 million RUB. 2012
Net profit (RAS) of IMPLANTA, ZAO made up 16.62 million RUB over 2012 compared to net loss of 62.83 million RUB over 2011, the company informed. Cost of goods sold grew 1.74 times to 982.45 million RUB from 564.83 million RUB; sales profit made up 33.56 million RUB compared to sales loss of 56.88 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|